Marinomed Biotech AG buy Savour
Start price
06.03.21
/
0%
€143.00
Target price
06.03.22
-
Performance (%)
-37.76%
End price
21.12.21
€89.00
Summary
This prediction ended on 21.12.21 with a price of €89.00. The BUY prediction by Savour for Marinomed Biotech AG performed very badly with a performance of -37.76%. This prediction was marked as speculative and is excluded from Savour's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marinomed Biotech AG | - | - | - | - |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
According to Savour what are the pros and cons of Marinomed Biotech AG for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Savour for this prediction
In the thread Marinomed Biotech AG diskutieren
Buy Marinomed Biotech AG